General Information |
| Organization Type - Primary: |
Academic / Research Institution |
| Organization Type - Secondary: |
None |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
International |
| Organization Description: |
| Vaccine development. We have worked in South Africa for 15 years on TB related projects and are currently funded for meningeal TB in RSA. |
| |
| Total number of staff in your organization: |
11 - 25 |
| Number of full-time staff who are directly involved with TB: |
11 - 25 |
| Number of part-time staff who are directly involved with TB: |
6 - 10 |
| Number of volunteers who are directly involved with TB: |
6 - 10 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$500,001-$1 MIL |
| How did you hear about the Stop TB Partnership: |
Stop TB communications |
| Why do you wish join the Stop TB Partnership: |
Network with other partners |
| |
| Are you a member of a Stop TB national partnership: |
United States of America |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| We are involved with Bill Jacob's lab for vaccine screening. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
United States of America |
| Which WHO region is the main focus of your work: |
African |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Brazil Mexico South Africa |